Table 6 The immunoreactivity of CD25 in nasal polyps
Variables | Number | CD25 immunoreactivity in nasal polyps | |||
|---|---|---|---|---|---|
- | +1 | +2 | +3 | ||
Eosinophilic nasal polyps | 21 | 2 (9.5%) | 0 | 5 (23.8%) | 14 (66.7%) |
Lymphocytic nasal polyps | 17 | 0 | 0 | 10 (58.8%) | 7 (41.2%) |
Variables | Number | CD25 immunoreactivity in nasal polyps | |||
|---|---|---|---|---|---|
- | +1 | +2 | +3 | ||
Eosinophilic nasal polyps | 21 | 2 (9.5%) | 0 | 5 (23.8%) | 14 (66.7%) |
Lymphocytic nasal polyps | 17 | 0 | 0 | 10 (58.8%) | 7 (41.2%) |